Navigation Links
International Drug & Explosives Detection Company Identa Corp Reports on New USA Marketing Representative
Date:7/9/2010

JERUSALEM, Israel, July 9, 2010 /PRNewswire-FirstCall/ -- IDenta Corp. (PINKSHEETS: IDTA) CEO Yaacov Shoham today issued a statement on the results of the three day meeting between executives of Identa Corp and the new United States representative for marketing of Identa products.

Mr. Shoham stated, "We have just concluded nine hours of intensive meetings each day for three days with our new representative in USA, and have established a detailed marketing plan to get Identa to the right position in the United States different markets. We have been able to take the information supplied by the former rep. Jant Pharmacal and analyze it and we have established an aggressive detailed marketing plan (with mile stones) on how to continue the penetration into the different American markets.

Based on the new reps background (30 years in American marketing, especially in the military and home land security) and his many successes in the relevant markets, we at Identa feel that we will be able to move ahead with our goals in a reasonable period. Finally we understand that we have found the right "partner" in the American markets."

Mr. Shoham further stated, "Both sides (Identa and the new rep) are committed to the new goals and will invest all the time, energy, money etc. to reach these goals in the first 3-year agreement. The new rep will be busy most of the time only with the Identa's different products. We have decided that everything will be done in day per day connections, and in a full transparency. We at Identa know that we have the best and most advance products on the market, and we need to make everything possible to make them very well known in the American markets. We are committed to getting the Identa name out to all sectors (public and private) of the American market. We want to make Identa a "household" word."

Information concerning IDenta's entire product line may be found at http://www.IDenta.biz

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, http://www.identa.biz.

    Contact:
    Yaacov Shoham
    IDenta Corp.
    CEO
    Tel: +972-52-6554487
    fpi@drugsdetector.com
    http://www.identa.biz
    mailto:fpi@drugsdetector.com



'/>"/>
SOURCE IDenta Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... 2017 Stock-Callers is currently reviewing the ... (NASDAQ: WMGI ), Varian Medical Systems Inc. (NYSE: ... MDXG ), and NuVasive Inc. (NASDAQ: NUVA ). ... to a negative finish on Thursday, January 12 th , ... while shares of health care companies in the S&P 500 ...
(Date:1/13/2017)... , January 13, 2017 ... "Transfection Reagents and Equipment Market by Method (Biochemical ... Application (Biomedical, Protein Production), End User - Global ... studies the global market from 2016 to 2021. ... Billion by 2021 from USD 715.4 Million in ...
(Date:1/13/2017)... 13, 2017 Wichita Laser Clinic ... treatments to Wichita, Kansas featuring ... treatments for skin rejuvenation, getting rid of unwanted tattoos, ... vascular lesions. "Since being in the aesthetics ... Wichita for laser tattoo removal and ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 16, 2017 , ... ... first-quality education and high-level training standards to an international multidisciplinary group of healthcare ... problems. As a way to further its mission at the grassroots level, iaedp ...
(Date:1/15/2017)... NY (PRWEB) , ... January 15, 2017 , ... In ... accounts in the United States for the asthma & allergy friendly mark. This certification ... to independently test and identify consumer products to be more suitable for the 60+ ...
(Date:1/15/2017)... ... January 15, 2017 , ... San Francisco Magazine recently ... Area counties for 2017. Almost 1,000 nominations were submitted and a little over ... Results were announced the magazine’s January 2017 issue . , Under the ...
(Date:1/14/2017)... ... 2017 , ... According to a December 9 article ... the risk of type 2 diabetes, Alzheimer’s, and cardiovascular disease. Southern California based ... linked to a Mediterranean diet are only some of the many reasons that ...
(Date:1/13/2017)... ... , ... A January 10 article in the Daily Star on ... with an emphasis on some new techniques that the publication says are becoming more ... casually to his patients and colleagues as Dr. J, comments that the best plastic ...
Breaking Medicine News(10 mins):